|
|
|
Health of Seniors
Return to Main Index
Automated
external defibrillators at home
As you read this, someone somewhere in the United States is collapsing
from a cardiac arrest. The odds are poor that she or he will survive
this sudden disruption of the heart’s normal rhythm. Most of the
1,000 or so people who go into cardiac arrest each day die because they
don’t get the treatment they need — an electric shock to
the heart — fast enough.
Heart-shocking devices were once found only in hospitals and ambulances.
Now they’re popping up in airports, movie theaters, fitness centers,
casinos, malls, office buildings, and other places. These public versions,
called automated external defibrillators (dee-FIB-rih-lay-tors),
are so easy to use that sixth graders who have never seen one before
can master their use in a minute or so, as shown in a 2002 study. This
ease of use, combined with the fact that 3 in 4 cardiac arrests happen
at home, have opened a national debate over whether it’s a good
idea to have a defibrillator at home.The chances of surviving a cardiac
arrest fall about 10% for each minute the heart stays in ventricular
fibrillation. Shock the heart back into a normal rhythm within two minutes,
and the victim has an 80% chance of surviving. Deliver that shock after
seven minutes — the average time it takes an emergency medical
team to arrive in many cities — and the odds are less than 30%.
If someone near you goes into cardiac arrest, calling 911 is a must.
Even if there’s a defibrillator nearby, you’ll need professional
help as soon as possible. CPR is also important because it keeps blood
flowing to the brain and other vital organs. Still, a home defibrillator
could let you restore a healthy heart rhythm several crucial minutes
sooner than emergency medical technicians.
Can home defibrillators help?
With a prescription from a doctor and $2,500 or so, you can buy a defibrillator
for your home, office, or car at many large pharmacies or medical supply
companies. The question is, should you? Experts in the areas of sudden
cardiac arrest, emergency medicine, and public health don’t see
eye-to-eye on this issue. Some argue that people who want to buy defibrillators
for their homes should be able to do so without needing a prescription
from a doctor. Others argue that people won’t maintain the devices
so they will be ready when needed, or that most people would be better
off spending some of the money on a health club membership and donating
the rest to their local emergency response team.
Researchers have collected relatively little evidence on the benefits
and risks of wider access to defibrillators. A few studies have examined
their use in public places. One, published in the October 17, 2002, Journal
of the American Medical Association, showed that 11 of 18 people
who collapsed with ventricular fibrillation over a two-year period in
Chicago’s three airports were revived, mostly by passers-by who
used highly visible and well-marked defibrillators.
But their use at home is uncharted territory. One project, Neighborhood
Heart Watch, is putting automated defibrillators in volunteers’ homes
in Indianapolis neighborhoods. When there’s a call to 911 about
a cardiac arrest in that neighborhood, it’s routed to both the
emergency services and the nearest home with a defibrillator.
Another study, the Home Automatic External Defibrillator Trial, sponsored
in part by the National Institutes of Health, aims to map out the benefits
and risks. It will give home defibrillators to 3,500 heart patients and
train their partners to use the devices. The partners of another 3,500
heart patients will get training in CPR, but no home defibrillator. The
results aren’t expected until 2007.
Who should have one?
A home defibrillator would probably be a good investment for anyone
who has survived a sudden cardiac arrest but who does not have a pacemaker
capable of shocking the heart (an implantable cardioverter/defibrillator,
or ICD). Owning this device might also make sense for someone with
severe heart failure, unstable angina, or other severe forms of heart
disease. So far, though, there’s no good evidence that home defibrillators
will save lives in this group of people.
Training is a must
If you decide to buy a defibrillator for your home, or if you just want
to be prepared for the chance you’ll someday need to use one in
a public venue, make the time now to take a class on using this device.
Why bother to go through training when these machines have been designed
for virtually mistake-free use? Several reasons. A class can help you
use the defibrillator with confidence and speed. It can help you deal
with unusual situations, such as where to apply the pads on someone with
an implanted pacemaker, a medication patch, or a hairy chest. It will
also teach you how to do CPR, an important part of the process.
The American Heart Association has developed a 3 1/2-hour course called “HeartSaver
AED for Lay Rescuers and First Responders.” To find the closest
training center that offers this course, call the AHA at 800-242-8721.
January 2003 Update
Back to Top
Medications
for postmenopausal osteoporosis prevention
Risk of osteoporosis increases after menopause, when levels of estrogen — which
helps preserve bone density — drop. Until recently, most doctors
recommended long-term hormone replacement therapy (HRT) to treat postmenopausal
women who need medication to prevent bone loss. But things changed after
results from a large trial on a common HRT drug showed that estrogen
plus progestin (as the medication Prempro) did more harm than good. An
increased risk for breast cancer and cardiovascular events outweighed
the benefits of less colorectal cancer and fewer fractures. (See the
Update from July 2002 for more information on the trial.)
Health experts now encourage most women who have been taking long-term
HRT for osteoporosis prevention to consider an alternative. Fortunately
there are several options. Each of the FDA-approved treatments (see chart)
has potential benefits and risks that women and their doctors should
weigh before making a decision. Even with HRT’s proven risks, it
may still be a good choice for certain women — especially in lower
doses, which recent data have shown to have bone benefits comparable
to higher, standard doses.
Approved medications
for osteoporosis prevention |
Medication |
How to take it |
Bone benefits |
Side effects |
Comments |
Alendronate (Fosamax) |
Orally, once daily in the morning or as a larger
dose once a week; take with 6–8 ounces of water and stay
upright for 30 minutes. |
Increases bone density at the spine and hip; reduces
spinal and hip fracture risk. Side effects uncommon. |
Heartburn, nausea, inflammation of the esophagus,
muscle pain. |
Interferes with cells that break down bone. Well-tolerated
when taken properly. |
Risedronate (Actonel) |
Orally, once daily in the morning or as a larger
dose once a week; take with 6–8 ounces of water and stay
upright for 30 minutes. |
Increases bone density at the spine and hip; reduces
spinal and hip fracture risk. Side effects uncommon. |
Abdominal pain, nausea, constipation, joint pain. |
Interferes with cells that break down bone. Well-tolerated
when taken properly. |
Raloxifene (Evista) |
Orally, once daily, any time. |
Increases bone density (but less so than alendronate
or risedronate); reduces spinal fracture risk. Side effects uncommon. |
Hot flashes, leg cramps, deep-vein blood clots. |
Acts like estrogen in bone but is an anti-estrogen
in breast tissue; may reduce breast cancer risk. |
Estrogen (Premarin, Estrace, other brands) |
Orally, once daily, any time; or weekly by skin
patch. |
Increases bone density; some evidence for fracture
reduction. |
Increases the risk for breast cancer (after 4–5
years) and cardiovascular events when combined with a progestin
(as Prempro) and taken orally. |
May be recommended if other medications are not
tolerable or menopausal symptoms persist. |
Sources: Boosting Bone Strength: A
Guide to Preventing and Treating Osteoporosis, Harvard
Health Publications, Boston, 2000; Managing Osteoporosis,
Part 3: Prevention and Treatment of Postmenopausal Osteoporosis, American
Medical Association, 2000; Osteoporosis: Guide to Prevention,
Diagnosis, and Treatment, Brigham and Women’s Hospital,
Boston, 2002 |
December 2002 Update
Back to Top
Dietary
Antioxidants May Decrease Risk of Alzheimer's Disease
Alzheimer’s disease (AD) is a complex disease that spreads through
the brain. It affects some 4 million Americans, causing memory loss,
impaired thinking, and changes in personality. Scientists have suspected
that substances called antioxidants — vitamin C, vitamin E, and
beta carotene, for example — may guard against AD. However, studies
testing the relationship between antioxidant supplements and the risk
of AD have not found consistent evidence of a benefit. But now two studies
published in the Journal of the American Medical Association have
found that high intakes of antioxidants from food may reduce the risk
of developing AD.
In the first study, researchers recruited 5,395 participants with an
average age of 67.7 years, who lived independently. All participants
reported their eating habits and went through two mental state examinations
to ensure that they were free of dementia at the start of the study.
During six years of follow-up, the researchers re-screened the participants
for Alzheimer’s disease. They found that high dietary intake of
vitamin C significantly reduced the risk of developing Alzheimer’s
disease and that the reduced risk of AD from high dietary intake of vitamin
E was also borderline significant. These antioxidants were most effective
at preventing AD in current smokers, compared with current non-smokers.
Use of dietary supplements was controlled in this study, so the beneficial
effects of vitamins C and E were only from food. Vitamin C is found in
large amounts in citrus fruits, kiwi, and broccoli, and good sources
of vitamin E include nuts, milk, and egg yolk.
In the second study, participants were also free of Alzheimer’s
disease at the beginning and completed a food frequency questionnaire.
The questionnaire helped researchers keep track of the intake of certain
foods and supplements. The 815 subjects were 65 years and older, and
were followed for four years.
After adjusting for age, education, sex, race, and presence of APOE
e4 (a genetic characteristic that makes a person more likely to develop
AD), the researchers found that those with the highest dietary intake
of vitamin E were 70% less likely to develop AD than those with the lowest
dietary intake of vitamin E. However, the highest Vitamin E intake for
the study was 363.6 International Units (IU) per day, well above the
Recommended Dietary Allowance of 22 IU.
The other dietary antioxidants tested in this study, vitamin C and beta
carotene, did not reduce the risk of AD. More research will need to be
performed to find out why vitamin C proved effective in one study but
not in the other. While dietary antioxidants are proving more effective
in reducing Alzheimer's risk than antioxidant supplements, these weren't
randomized, clinical trials, so these studies won't translate into dietary
recommendations.
August 2002 Update
Back to Top
Physical activity benefits
all ages
The frail health often associated with aging is in large part due to
physical inactivity, according to a report released by the U.S. Department
of Health and Human Services (HHS). It also advises that it’s never
too late to benefit from becoming physically active.
The report cites that even moderate levels of activity — such
as washing a car or raking leaves — can produce considerable benefits
that can be even more noticeable in older adults. Regular exercise improves
cholesterol levels, reduces blood pressure, cuts body fat, and lowers
blood sugar. Physical activity also improves bone and muscle strength.
All in all, people who exercise live longer — and they also live
better.
Current guidelines recommend at least 30 minutes of moderate physical
activity a day. However, few older Americans reach this level. Lack of
physical activity and poor diets are the major causes of obesity, an
epidemic that is affecting people of all ages.
In the '70s and '80s, doctors were telling Americans to run; now, they
are asking people to walk. Walking can be a moderately intense aerobic
activity. But even at a more relaxed pace, walking has huge benefits.
The distance actually seems more important than the pace — and
it doesn't take heroic distances to get real benefit. In 1993, the Harvard
Alumni study found that men who walked just 1.3 miles a day had a 22%
lower death rate than those who walked less than 0.3 mile a day.
Strong muscles also improve your health. So set aside 15 minutes two
or three times a week for resistance or strength training as well as
10–15 minutes at least three times a week for stretching exercises.
The HHS report provides strategies that individuals, doctors, and even
communities can follow to promote physical activity. Individuals are
encouraged to take part in activities that they enjoy and to make them
a daily part of life. Doctors should help patients start and continue
these regimens and overcome any difficulties they encounter. Communities
can establish programs tailored to seniors’ physical activity needs
and improve walking or bike trails.
The complete report is available at www.ahrq.gov/ppip/activity.htm
August 2002 Update
Back to Top
Annual PSA Test May Not be Necessary for All
Older Men
Prostate cancer is the second leading cause of death for men in the
United States. And while the chance of being diagnosed with prostate
cancer over a lifetime may be as high as 20%, the chance of dying of
prostate cancer is only about 3%. But the risk of prostate cancer increases
with age. More than 75% of all cases occur in men over 65, and about
40% of men over 80 have the disease. When it is diagnosed early, prostate
cancer is more likely to be treated successfully. Cure rates are excellent
for cancer that is discovered and treated when it is still confined to
the prostate gland. About 95% of men with localized prostate cancer treated
by surgery are alive after five years.
The prostate-specific antigen (PSA) test is a primary test for finding
early-stage prostate cancer. PSA is a protein produced by the prostate
gland, and PSA levels become elevated in men with prostate cancer. Although
some respected groups recommend an annual PSA test for all men over age
50, the annual PSA test remains controversial. That is, in part, because
it has a high chance of being falsely negative (20%-40% of men with prostate
cancer have normal levels of PSA) or falsely positive (PSA levels may
be elevated in men with noncancerous prostate conditions).
At a meeting of the American Society of Clinical Oncology, researchers
presented findings that indicated that an annual PSA test may not be
warranted in men over 50 with an initial normal PSA (04 nanograms/milliliter).
For five years, researchers tracked the annual PSA test results of 27,863
men ages 5574 whose PSA levels were initially normal. . They found
that 98.6% of men with a PSA result of less than 1 ng/ml at baseline
would remain negative after 4 more annual tests and that 98.8% of men
with a baseline PSA of 12 ng/ml would have a negative PSA test
the following year.
Based on these results, the researchers concluded that performing a
PSA test every five years on men with an initial PSA less than 1 ng/ml
and every two years for men with a PSA of 12 ng/ml would reduce
the number of PSA tests performed by 55%. This would save money and help
men avoid the anxiety associated with yearly prostate tests.
July 2002 Update
Back to Top
Healthy Diet
Eradicates Need for Trendy Supplements in Elderly
Magazine ads and television commercials tout dietary supplements that
claim to be a veritable fountain of youth for seniors. Images of grandparents
able to keep up with their grandkids convince older adults that shakes,
energy bars, and special vitamins will help boost energy and decrease
signs of aging.
Health experts, however, stress that a well-balanced diet rich in fruit
and vegetables is just as effective and probably safer. But many older
adults skip meals and eat small amounts of fruits and vegetables, citing
reasons ranging from rotten teeth to unhappiness with eating alone.
While doctors acknowledge that nutritional shakes and energy bars are
helpful for seniors who need to gain weight or have trouble chewing or
swallowing, those who eat a balanced diet or stay active do not need
them.
In spite of what the experts have said, the savvy advertisements are
convincing millions of seniors that they need these expensive supplements,
some of which have not even been proven safe.
Herbs are also a source of concern. Saw palmetto, an extracts made from
the fruit of the saw palmetto plant, is promoted as a treatment for an
enlarged prostate. Many people believe that herbs are natural and therefore
safe but this is not the case. In fact, as with most nonprescription
herbal products, the composition of the extract and the dosage have not
been standardized and the supplement is not regulated by the FDA. If
you decide to use saw palmetto, tell your doctor in order to alert him
or her to possible interactions between it and other medications you
may be taking.
People who are on strict diets — like those prescribed for kidney
disease, heart disease, or diabetes — must be especially wary of
adding any special supplements to their diet. Regardless of whether health
problems are present, you should always consult a physician before starting
any dietary regimen.
May 2002 Update
Back to Top
New Guidelines for Rheumatoid Arthritis
Treatment
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting
more than 2 million people in the United States. It causes pain, stiffness,
and swelling in the joints, as well as inflammation in organs. Guidelines
for the management of the disease were first created in 1996, but significant
developments since then prompted the American College of Rheumatology
to publish an updated version in the February 2002 issue of its journal, Arthritis & Rheumatism.
A key addition to the new guidelines is the emphasis on early diagnosis
and treatment. Recent studies have confirmed that if RA is treated early
and aggressively, the course can be altered and the onset of joint destruction
can be delayed. The report advises patients to consider nonsteroidal
antiinflammatory drugs (aspirin, ibuprofen), glucocorticoid injections,
or prednisone to control symptoms once diagnosed. But the new guidelines
recommend most people begin treatment with the more potent disease-modifying
antirheumatic drugs (DMARDs) within three months of diagnosis. If prognosis
is poor, however, DMARDs should be initiated as soon as the diagnosis
is confirmed.
The guidelines give information on the efficacy, potential side effects,
cost, and administration methods of several new drugs being used in the
treatment of RA. These new therapies include three genetically engineered
biologic response modifiers (entanercept, infliximab, and anakinra) which
target chemicals that cause inflammation. The use of entanercept and
infliximab, which work by blocking important inflammation messenger proteins,
represent a major advancement in RA treatment. Also presented is a new
DMARD, Leflunomide, which slows the structural damage brought on by RA.
The guidelines recommend using the aggressive drugs in combination for
example, a biological agent plus a DMARD or two DMARDs.
These new therapeutic options are already being used in the treatment
of RA. But for physicians who treat the disorder, the primary value of
the new guidelines is the parameters they set for RA therapy and medications.
April 2002 Update
Back to Top
Advanced Macular Degeneration and Nutritional
Supplements
Nutritional supplements may help slow the progression of advanced macular
degeneration (AMD), the most common cause of vision loss in people over
age 55, a new study suggests.
The Age-Related Eye Disease Study (AREDS), reported in the October 2001 Archives
of Ophthalmology, is the largest clinical trial to have tested the
impact of nutritional supplements on AMD and cataracts. AREDS involved
nearly 5,000 women and men, ages 55-80, at 11 clinical centers nationwide.
Participants in the macular degeneration portion of the study were divided
into groups depending upon the severity of their condition. They received
one of the following daily regimens: 1) antioxidants (500 mg vitamin
C, 400 IU vitamin E, 15 mg beta-carotene), 2) zinc (80 mg, plus 2 mg
copper to prevent anemia), 3) a combination of the antioxidants and zinc,
or 4) a placebo. Participants were evaluated every six months for vision
loss and annually for retinal changes.
Over the seven-year study, combined antioxidants and zinc reduced the
risk for progression to advanced AMD by 25%, compared with placebo, among
those who already had extensive intermediate or large drusen or advanced
AMD in one eye. This treatment also reduced the AMD-related loss of visual
acuity by about 19%. Antioxidants or zinc alone reduced the risk, but
to a lesser extent. AREDS subjects with early or no AMD got no measurable
benefit from the supplements. In the companion study of cataract development,
antioxidants and zinc (separately or in combination) had no beneficial
effect.
Though participants reported no major side effects, the long-term consequences
of taking these nutrients at levels above the Recommended Dietary Allowance
(RDA), as AREDS participants did, are unknown.
January 2002 Update
Back to Top
Aggressive Therapy for Older Hearts
There's no question coronary artery bypass grafting and angioplasty
can relieve the pain of angina, prevent heart attacks, and add years
to the lives of people with blocked coronary arteries. But most studies
have excluded people over age 70, so the benefits of aggressive therapy
is less clear in the older patient.
Two studies from Switzerland and Canada provide good news for older people
who may need bypass surgery or angioplasty. Swiss researchers compared
the effects of medical therapy and invasive therapy among more than 300
men and women with angina, all of whom were age 75 or over. They reported
the results in the journal Lancet. After six months, the frequency
and severity of chest pain had lessened and the quality of life had improved
in both groups. But the improvements were substantially greater, and
the heart attack rate substantially lower, among those who had undergone
bypass surgery or angioplasty.
The Canadian study, which appeared in the Canadian Medical Association
Journal, compared the effects of bypass surgery on patients in their
80s and those in their 70s. The investigators found it as safe and effective
for octogenarians as it was for septuagenarians and reported that it
cost about the same in either group.
Neither of these studies provides blanket assurance that an invasive
procedure like bypass surgery or angioplasty is right for every older
person with blocked coronary arteries. Older candidates for bypass surgery
or angioplasty may want to focus on quality-of-life issues. Recovery,
for example, may be a completely different experience for older people.
December 2001 Update
Back to Top
Statins Associated With Lower Dementia Risk
Most people who develop dementia - poor memory and intellectual functioning
that often accompanies old age - have Alzheimer's disease. But a small,
yet sizable group of people appear to develop dementia from a narrowing
of the arteries supplying the brain. The lack of blood can lead to many
small areas of damage to the brain; each too small to be noticeable as
a "stroke," but collectively devastating in their effect. This syndrome
is called "vascular dementia" to differentiate it from Alzheimer's disease
and other types of dementia.
Presumably because high cholesterol levels contribute to the damage of
brain's blood vessels, researchers have looked for evidence that people
who use statins might have a lower rate of dementia. Statins are the
most widely used cholesterol-lowering drugs. In addition to protecting
the brain's arteries from atherosclerosis, some scientists believe statins
may also help protect the brain against non-vascular forms of dementia,
including Alzheimer's disease.
A recent study examined the relationship between statin use and types
of dementia among people living in the United Kingdom. The researchers
identified 284 people with dementia, and matched them with 1,080 "control" subjects
of similar age and sex, but without dementia. After adjusting statistically
for a wide range of clinical information, the researchers found statin
use was associated with a 71% reduction in dementia risk.
Could statins really cut the risk for dementia by two-thirds or more?
It seems unlikely, since other studies haven't suggested protective effects
of this size. On the other hand, this study adds to several other laboratory
and epidemiological investigations that suggest statins might provide
some benefit in the protecting the brain - if for no other reason than
lower cholesterol levels lead to healthier brain arteries. No one should
start taking statins as a strategy for preventing dementia, but these
data do provide another reason for people with elevated cholesterol levels
who are on these medications to be sure they take them as prescribed.
October 2001 Update
Back to Top
Killing H. Pylori Helps Prevent Gastrointestinal
Bleeding in Patients Taking Low-Dose Aspirin
Many people take low-dose aspirin on a daily basis to help prevent heart
attacks. Others take larger doses of stronger nonsteroidal antiinflammatory
drugs (NSAIDs), such as naproxen (Anaprox, Aleve, others), to relieve
musculoskeletal pain such as that caused by arthritis. When taken on
a regular basis, however, NSAIDs often cause ulcers and gastrointestinal
(GI) bleeding. Ulcers, which are raw, crater-like breaks in the mucosal
lining of the digestive tract, may also be caused by excess acid production
and a bacterium known as Helicobacter pylori (H. pylori).
In a study published in the New England Journal of Medicine, researchers
enrolled 400 patients with a history of GI bleeding who were taking aspirin
or other NSAIDs to prevent heart disease or to control musculoskeletal
pain. They set out to find whether eradicating H. pylori infection
reduces the risk of recurrent GI bleeding in these patients. For six
months, 250 patients were given an 80 mg "baby" aspirin once
per day, while the remaining 150 patients received 500 mg of naproxen
twice per day. Within each of the two groups, patients were randomly
assigned to take either a daily dose of omeprazole (Prilosec), an acid-suppressing
medication, or a one-week antibiotic treatment to eradicate H. pylori infection,
followed by placebo for the remainder of the trial.
The researchers found that in patients taking aspirin, those who were
treated for H. pylori had a 1.9% risk of GI bleeding while the
risk for those taking omeprazole was 0.9%. In other words, for patients
on low-dose aspirin, the treatments were almost equal.
The results were very different for patients taking naproxen. 19% of
the naproxen patients who had H. pylori treatment suffered from
recurrent bleeding. In contrast, only 4% of the omeprazole group did.
The study suggests that patients with a history of GI bleeding who take
low-dose aspirin to prevent heart attacks should be tested for H.
pylori infection and treated if the infection is found to be present.
Patients taking non-aspirin NSAIDs and who have experienced GI bleeding
are more likely to benefit from acid-suppressing therapy.
April 2001 Update
Back to Top
Ipriflavone Not Effective for Osteoporosis
For years, estrogen replacement therapy was the drug of choice for treatment
of osteoporosis in postmenopausal women. But the potential risks of HRT
sent women searching for alternatives. One option was phytoestrogens plant-based
compounds that bind to estrogen receptors in the body, presumably mimicking
the beneficial effects of estrogen without its potential risks. Of the
phytoestrogens, the most promising was ipriflavone, a synthetic
version of a naturally occurring isoflavone, a type of phytoestrogen.
But a well-designed study published in the March 21, 2001, Journal
of the American Medical Association refutes the positive results
of previous studies, demonstrating that ipriflavone does not prevent
bone loss or reduce the risk of fracture in postmenopausal women. It
also cautions that ipriflavone lowers levels of lymphocytes, an effect
that could make women more vulnerable to infection.
In the JAMA study, members of the Ipriflavone Multicenter European
Fracture Study Group assigned 474 postmenopausal white women with low
bone mass aged 45 to 75 to either 200 mg of ipriflavone taken three times
per day or a placebo for the three-year duration of the trial.
At the end of the trial, the researchers found no significant difference
between the treatment groups in regard to bone mineral density measured
at the lumbar spine, total hip, and distal radius; in biochemical markers
of bone formation or bone resorption; or in the number of vertebral fractures
suffered by the women.
The major difference was that women treated with ipriflavone experienced
significant drops in their lymphocyte concentration. 13.2% of the ipriflavone-treated
women developed lymphocytopenia, a condition defined as a total
lymphocyte concentration below 500/µL. Of these women, 52% returned
to normal lymphocyte values within one year of discontinuation of the
drug; 81% returned to normal within two years.
In reviewing their findings, the researchers cautioned against the use
of ipriflavone to treat osteoporosis.
Women throughout much of the world have used ipriflavone since 1969 to
treat osteoporosis. More recently it has been sold over-the-counter in
the United States as Ostovone.
April 2001 Update
Back to Top
Early Cognitive Impairment Following Coronary Bypass
May Predict Lasting Cognitive Impairment
More than 500,000 coronary-artery bypass grafting (CABG) surgical
procedures are performed in the United States each year to bypass blood
around clogged arteries and improve the flow of blood and oxygen to the
heart. Advances in anesthesia, surgical procedure, and other areas have
made CABG a relatively safe procedure for an expanding group of heart
disease patients including older and other high-risk patients. But while
the risk of death after CABG has decreased, the risk of cognitive impairment
has not. Growing evidence suggests that many patients experience short-term
cognitive impairment after CABG.
A recent study in the New England Journal of Medicine confirmed
not only the high incidence but also the persistence of cognitive decline
following the procedure. It also showed that patients who exhibit signs
of cognitive decline immediately following surgery are more likely to
continue to suffer from cognitive decline at up to five years after surgery.
Researchers from Duke University Medical Center tested the cognitive
function of 261 patients before they underwent CABG surgery, and then
again before discharge from the hospital and at six weeks, six months,
and five years after the CABG procedure. 172 patients, whose average
age was 61, completed all of the follow-up.
The researchers found that the incidence of cognitive decline was 53%
at discharge, 36% at six weeks, 24% at six months, and 42% at five years.
The pattern demonstrated improvement of cognitive functioning within
the first six months, and then a decline between six months and five
years after surgery.
Even after controlling for age, education level, and baseline test score,
patients who experienced cognitive decline immediately following surgery
were at a significantly increased risk for long-term cognitive decline
and a reduced level of overall cognitive functioning.
It remains unclear why early, postsurgical cognitive decline is associated
with a greater risk of long-term cognitive decline.
April 2001 Update
Back to Top
Sertraline Effectively Treats Depression in Alzheimer's
Patients
A large portion of the 4 million Americans with Alzheimer's disease
(AD) a progressive degenerative disease of the brain that results
in memory loss, impaired thinking, and personality change also
suffer from major depression. This can make the already devastating condition
even more difficult, not only for patients, but also for their caregivers.
Until recently, the efficacy of antidepressants in such patients was
uncertain. Now, a study from The American Journal of Psychiatry shows
that sertraline (Zoloft) a type of antidepressant known as a selective
serotonin reuptake inhibitor (SSRI) is more effective than placebo in
reducing depression in patients with AD. This study is the first to show
both the efficacy and safety of an SSRI in treating depression in patients
with AD.
A team of researchers from the Johns Hopkins University School of Medicine
and the Copper Ridge Institute in Maryland selected 22 patients with
Alzheimer's disease who also met the Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV) criteria for having had a major depressive
episode. Over the course of the 12-week double-blind trial, the scientists
gave the patients, whose average age was 77, either a placebo or up to
150 milligrams of sertraline per day. All patients and caregivers received
illness education, encouragement, and emotional support every three weeks
over the course of treatment.
The scientists found that AD patients who had been given sertraline experienced
significantly greater improvements in mood than patients who received
a placebo. In addition, the sertraline patients experienced less decline
than placebo patients in participation in daily activities.
Side effects of the drug included tremor, restlessness, and gastrointestinal
complaints. But all were mild, and there was no significant difference
in side effects between the sertraline group and the placebo group.
April 2001 Update
Back to Top
Reducing Your Risk of Deep Vein Thrombosis During
Airline Travel
Deep vein thrombosis (DVT), recently featured in the news as "economy
class syndrome," is the formation of a blood clot in the deep veins
of the legs while sitting particularly in the cramped seats of
an airplane (be it economy class or first class), car, bus, or train for
long periods. You move less in tight quarters, causing circulation to
decrease and allowing blood to collect and form a clot. The blood clot
may cause pain and swelling in the legs. Serious, even fatal complications
can occur if the blood clot breaks loose in the blood stream and travels
to the heart or lungs. Older people, and those who are obese or have
a family history of DVT tend to be at the highest risk.
While a blood clot can result from a number of causes, some studies suggest
an association between blood clots and airplane travel. Many doctors
believe this connection is simply a result of being unable to move around,
and not from sitting in economy class seats or in an airplane, per
se. However, it is possible that pressurized air and dehydration
may also play a role in the connection between air travel and blood clots.
Many airlines have already begun to address this health issue by preparing
warning pamphlets for their passengers, including articles in their in-flight
magazines, posting notices on their Websites, or creating in-flight videos
offering exercises aimed at prevention. A member of the parliament in
Australia has even called for treadmills to be installed in airplanes
that carry passengers for six or more hours.
While treadmills may or may not appear on airplanes in the near future,
you can address this issue on your next lengthy flight by taking a few
simple measures to help prevent blood clotting.
- Wear loose-fitting, comfortable clothing during the flight.
- Eat a small meal and drink plenty of fluids to help increase blood
circulation. Avoid alcohol and caffeine, as these contribute to dehydration.
- Do not cross your legs while seated and make sure you adjust your
position every half hour.
- You may want to wear elastic support hose to increase circulation
in your legs.
- Most importantly, try to walk up and down the aisle at least once
an hour. Even standing in front of your seat and gently shaking out
your legs or slowly rising up on your toes can help.
- If you cant get out of your seat, you can do the following
exercises in your seat to increase blood circulation. Perform each
exercise for 15 seconds, once an hour.
- Ankle rotations: Draw a circle with your toes, rotating clockwise
and then counterclockwise with both feet.
- Foot pumps: Slowly alternate between flexing and pointing your toes.
- Leg lifts: With your knee bent, lift your leg up off the seat and
hold for a few seconds. Alternate legs.
- Head and shoulder rotations: Gently roll your head clockwise and
then counterclockwise, keeping your shoulders relaxed. Then gently
roll your shoulders forwards and backwards.
- Toe reach: Slowly bend forward and extend your arms down towards
your toes and then gently sit back up.
- People who are at high risk for blood clotting due to other conditions
should speak with their physician for additional advice before traveling.
Studies do not agree on how long a flight needs to be to pose a risk
of blood clotting. A few studies even suggest that there is no association
between blood clots and air travel. Clearly, more research is necessary.
However, while we wait for a definitive answer to these questions, heeding
these simple instructions may help prevent problems.
March 2001 Update
Back to Top
FDA Approves Weekly Dose of Fosamax (alendronate)
for Osteoporosis Treatment and Prevention
The FDA recently approved once-a-week doses of Fosamax (alendronate)
for the prevention and treatment of osteoporosis. The weekly dose for
prevention is 35 mg while the weekly dose for treatment is 70 mg. Fosamax,
which was already approved for once-a-day use, works by slowing bone
loss.
The main advantage of the once-a-week version is convenience. Doctors
recommend that Fosamax be taken first thing in the morning, on an empty
stomach, approximately 30 minutes before breakfast, and that patients
not lie down for at least 30 minutes after taking the medication. Patients
may find that they prefer to adhere to this routine only once a week,
rather than every day.
FDA approval was based largely on a two-year clinical trial that showed
that for postmenopausal women, a weekly 70 mg dose of alendronate was
just as effective at increasing bone mineral density as a 10 mg daily
dose. The study included 1,258 postmenopausal women with a mean age of
67. The once-weekly alendronate dose was effective regardless of the
womens underlying condition, age, bone mineral density (BMD), or
pre-existing fractures.
Compared with the daily dose, 70 mg of alendronate once a week was better
tolerated and produced fewer serious upper gastrointestinal and esophageal
problems. The weekly dose also produced similar gains in bone mineral
density at the lumbar spine, total hip, femoral neck, hip, and total
body sites.
February 2001 Update
Back to Top
More Evidence That Pumping Iron Is Good for Seniors
Too
Two recent studies published in the Journal of the American Geriatrics
Society add more data to the mounting evidence that exercise is
important at any age and that resistance (or weight) training has considerable
benefits for older adults.
It is well known that strength training can improve muscle strength
and balance of particular importance in preventing falls and fractures
in seniors. Research on just how much training is required to derive
these benefits has been conducted primarily in younger people. The first
study looked at how often older people must exercise. Forty-six people
(both men and women) between the ages of 65 and 79 years were assigned
to a resistance exercise program to be performed one, two, or three days
per week. Study results showed that seniors exercising one or two times
per week had about the same improvements in muscle strength and coordination
as did those who exercised three times per week.
Researchers at the University of Maryland Exercise Science Laboratory
conducted the second study, which was designed to look at the effects
of strength training on resting blood pressure in older adults (the average
age in this study was roughly 69). Eleven men and 10 women who had not
been exercising regularly were assigned to a six-month training program
using weight lifting machines. Not only did the study volunteers show
significant increases in upper- and lower-body strength, but both groups
also demonstrated significantly lowered diastolic blood pressure (the
bottom number in a blood pressure reading). Interestingly, only the men
in the group experienced significantly lowered systolic blood pressures
(the top number in a blood pressure reading). Perhaps the best news was
that the reduction in blood pressure brought these patients readings
into the normal range. Investigators also noted that the improvement
in blood pressure was not related to weight loss associated with increased
exercise.
The bottom line, however, is not news at all. Exercise is important,
good for individuals of every age group, and the health benefits are
many. Even doing a little is a whole lot better than doing no exercise
at all.
Journal of the American Geriatrics Society, Vol. 47, No. 10,
pp. 120814.
Journal of the American Geriatrics Society, Vol. 47, No.
10 pp. 121521.
Back to Top
Purchasing Prescriptions Online
Your mother always warned you about taking candy from strangers. Now
a new study cautions consumers about buying prescription drugs from electronic
strangers. The Internet offers unparalleled access to health care information
and increasingly unparalleled shopping for prescription pharmaceuticals.
However, a survey conducted by researchers at the University of Pennsylvania
found these online pharmacies are, at best, expensive alternatives to
traditional pharmacies and at worst, potentially dangerous substitutes
for your doctor's advice.
The study reviewed Internet sites offering prescription drugs directly
to the public. Information examined included the procedures for obtaining
medication, prescription and shipping costs, cost of physician consultations,
and physician qualifications. Study investigators then compared the prices
of consultations and two popular medications Viagra (for impotence)
and Propecia (for hair loss) with prices at the clinics and pharmacies
in their area.
Thirty-seven of the 45 sites required a prescription or online physician
approval before purchase. Nine sites, all based overseas, required no
physician consent. Most consultations consisted of online medical history
forms and limited interaction through e-mail. The resulting medication
was 10% more expensive on the Web before adding shipping costs. Consultation
costs, too, were higher, averaging 15% above clinic rates.
While the additional costs might not worry those consumers more interested
in convenience or privacy, the potential risks should. The dangers associated
with sites that do no require any form of physician approval are obvious.
However, none of the sites, even those requiring a doctor's approval,
revealed the names, specialties, or qualifications of their physicians.
The lack of a physical exam likely increases the risk of misdiagnosis,
and only five sites listed their business' physical address, should a
problem occur.
In June of 1999, the American Medical Association issued a statement
condemning doctors who diagnose patients without access to the patient's
medical records, a reasonable likelihood of follow-up, or, at least,
a physical exam. More regulations will certainly follow. Until then,
consumers should think twice before surfing to the online pharmacy. For
more information on managing your medications, see page 1,156 of the Family
Health Guide.
Back to Top |